Need for the Change of Anticoagulants In The Reproductive Age Group Women

Hemorrhagic ovarian cysts usually result from haemorrhage into a corpus luteum or other functional cysts. It is a frequent and potentially life threatening complication in women on chronic anticoagulation therapy. Surgical management has been a traditional approach in managing hemorrhagic ovarian cyst. However conservative management is now dominating the trend in carefully selected patients .For prevention of recurrence of ovulation related bleeding it is mandatory to use a ovulation suppressing agent during the monthly  follow up. Here we present two case reports who had been receiving oral anticoagulants – Vit K antagonist for prosthetic heart valves and are treated as a result of ruptured corpus luteal cyst. One was treated surgically other was treated conservatively. They were discharged with advise of DMPA for ovulation suppression in the follow up. Even though VKA’S are cost effective and efficacious in preventing valve thrombus, because of life threatening hemorrhage and periodic INR monitoring necessitate the need for researches to find an safe and effective alternative newer oral anticoagulants for women in reproductive age group.